Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for chronic pelvic pain with levator spasm
ACTRN12605000559617Phase 4Completed
- Sponsor
- Allergan
- Start
- Jan 2004
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in chronic prostatitis (CP), chronic proctalgia and Pelvic floor hypertonicity (PFH) (2 arms), sponsored by Allergan. Primary endpoints: VAS pain assessment, Bladder and bowel symptoms and 7 more. Started Jan 2004; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
chronic prostatitis (CP)chronic proctalgiaPelvic floor hypertonicity (PFH)
Beyond the preview
Go deeper on ACTRN12605000559617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000559617.